Three cases of primary cutaneous lymphoblastic lymphoma: Microarray-based comparative genomic hybridization and gene expression profiling studies with review of literature

Leukemia and Lymphoma

Volumn 53, Issue 10, 2012, Pages 1978-1987

  Vezzoli, Pamela ^a   Novara, Francesca ^b   Fanoni, Daniele ^a   Gambini, Daniele ^a   Balice, Ylenia ^a   Venegoni, Luigia ^a   Paulli, Marco ^b   Crosti, Carlo ^a   Berti, Emilio ^a,c  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Chromosomal aberrations; Gene expression profiling (GEP); Microarray comparative genomic hybridization (CGH); Precursor T cell lymphoblastic lymphoma; Primary cutaneous lymphoblastic lymphoma; Trisomy 4

Indexed keywords

ASPARAGINASE; BLEOMYCIN; CALCIUM; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FOLINIC ACID; HYDROXYUREA; METHOTREXATE; PREDNISONE; TIOGUANINE; VINCRISTINE;

ADULT; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER REGRESSION; CHILD; CHROMOSOME 1P; CHROMOSOME 4; CHROMOSOME ANALYSIS; CHROMOSOME LOSS; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE; GENE EXPRESSION PROFILING; GENETIC GAIN; HUMAN; HUMAN TISSUE; LYMPHOBLASTOMA; MALE; MICROARRAY ANALYSIS; PHENOTYPE; PRE B LYMPHOCYTE; PRESCHOOL CHILD; PRIMARY CUTANEOUS LYMPHOBLASTIC LYMPHOMA; PRIORITY JOURNAL; REVIEW; SKIN LYMPHOMA; TRISOMY;

ADULT; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOPHENOTYPING; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; SKIN NEOPLASMS;

EID: 84865761486     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2011.618233     Document Type: Review

References (41)

1. Borovitz MJ, Chan JKC. Precursor lymphoid neoplasms. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHOclassification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARCPress; 2008. pp 167-178.
2. Lin P, Jones D, Dorfman DM, et al. Precursor B-cell lymphoblastic lymphoma. Am JSurg Pathol 2000;24:1480-1490.
3. Bergeron C, Pacquement H, Perel Y, et al. Treatment of childhood Tcell lymphoblastic lymphoma (TLL), results of the SFOPLMT96. Blood 2005;106(SUPPL. 1): Abstract 929.
4. Uyttebroeck A, Suciu S, Laureys G, et al. Treatment of childhood T-cell lymphoblastic lymphoma according to the strategy for acute lymphoblastic leukemia, without radiotherapy: long term results of the EORTCCGL58881 trial. Eur JCancer 2008;44:840-846.
5. Trupiano JK, Bringelsen K, His ED. Primaty cutaneous lymphoblastic lymphoma presenting in an 8-week old infant. JCutan Pathol 2002;29:107-112.
6. Shafer D, Wu H, Al-Saleem T, et al. Cutaneous precursor B-cell lymphoblastic lymphoma in 2 adult patients. Arch Dermatol 2008;144:1155-1162.
7. Sander CA, Medeiros LJ, Abruzzo LV, et al. Lymphoblastic lymphoma presenting in cutaneous sites. JAm Acad Dermatol 1991;25:1023-1031.
8. Cordell JL, Falini B, Erber WN, et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAPcomplexes). JHistochem Cytochem 1984;32:219-229.
9. Sambouk J, Fritsch E, Maniatis T. Molecular cloning. In: Alaboratory manual, Vol. III. New York: Cold Spring Harbor Laboratory Press; 1989. E.3.
10. Novara F, Beri S, Bernardo ME, et al. Different molecular mechanisms causing 9p21 deletions in acute lymphoblastic leukemia of childhood. Hum Genet 2009;126:511-520.
11. Muljono A, Graf NS, Arbuckle S. Primary cutaneous lymphoblastic lymphoma in children: series of eight cases with review of the literature. Pathology 2009;41:223-228.
12. Maitra A, McKenna RW, Weinberg AG, et al. Precursor B-cell lymphoblastic lymphoma. Am JClin Pathol 2001;115:868-875.
13. Kahwash SB, Qualman SJ. Cutaneous lymphoblastic lymphoma in children: report of six cases with precursor B-cell lineage. Ped Develop Pathol 2002;5:45-53.
14. Link MP, Roper M, Dorfman RF, et al. Cutaneous lymphoblastic lymphoma with pre-Bmarkers. Blood 1983;61:838-841.
15. Biasotti S, Sementa AR, Zupo S, et al. Anew pediatric case of cutaneous pre-Blymphoblastic lymphoma. Haematologica 2001;86:997-998.
16. Kawakami T, Kimura S, Kinoshita A, et al. Precursor B-cell lymphoblastic lymphoma with only cutaneous involvement. Acta Dermatol Venereol 2009;89:540-541.
17. Shon W, Vitkovski T, Cappel MA. Primary cutaneous precursor B-cell lymphoblastic lymphoma in an elderly patient. JDermatol 2011;38:206-208. 33.
18. Soslow RA, Baergen RN, Warnke RA. B-lineage lymphoblastic lymphoma is a clinic pathologic entity distinct from other histologically similar aggressive lymphomas with blastic morphology. Cancer 1999;85:2648-2654.
19. Gupta R, Borkataky S, Aggarwal D, et al. Primary cutaneous B-cell lymphoblastic lymphoma. Indian JDermatol Venereol Leprol 2008;74:652-654.
20. Kim JY, Kim YC, Lee ES. Precursor B-cell lymphoblastic lymphoma involving the skin. JCutan Pathol 2006;33:649-653.
21. Schmitt IM, Manente L, Di Matteo A, et al. Lymphoblastic lymphoma of the pre-Bphetotype with cutaneous presentation. Dermatology 1997;195:289-292.
22. Chimenti S, Fink-Puches R, Peris K, et al. Cutaneous involvement in lymphoblastic lymphoma. JCutan Pathol 1999;26: 379-385.
23. Osone S, Hosoi H, Tanaka K, et al. Acase of a Ewing sarcoma family tumor in the urinary bladder after treatment for acute lymphoblastic leukemia. JPediatr Hematol Oncol 2007;29: 841-844.
24. Borgmann A, Zinn C, Hartmann R, et al. Secondary malignant neoplasms after intensive treatment of relapsed acute lymphoblastic leukaemia in childhood. Eur JCancer 2008;44:256-268.
25. Ducassou S, Ferlay C, Bergeron C, et al. Clinical presentation, evolution and prognosis of precursor B-cell lymphoblastic lymphoma in trials LMT96, EORTC58881 and EORTC58951. Br JHaematol 2011;152:441-451.
26. Yeh KH, Cheng AL, Su IJ, et al. Prognostic significance of immunphenotypes in adult lymphoblastic lymphomas. Anticancer Res 1997;17:2269-2272.
27. Bernard A, Murphy SB, Melvin S, et al. Non-T, non-Blymphomas are rare in childhood and associated with cutaneous tumor. Blood 1982;59:549-554.
28. Donlon JA, Jaffe ES, Braylan RC. Terminal deoxynucleotidyl transferase in malignant lymphomas. NEngl JMed 1977;297: 461-464.
29. Bollum FJ. Terminal deoxynucleotidyl transferase as a hematopoietic cell marker. Blood 1979;54:1203-1215.
30. Janossy G, Hoffbrand AV, Greaves MF. Terminal transferase enzyme assay and immunological membrane markers in the diagnosis of leukemia: a multiparameter analysis of 300 cases. Br JHaematol 1980;44:221-234.
31. ], Cattoretti G, John K, et al. Terminal deoxynucleotidyl transferase staining of malignant lymphomas in paraffin sections. Mod Pathol 1994;7:582-586.
32. Facchetti F, Jones DM, Petrella T. Blastic plasmacytoid dendritic cell neoplasm. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHOclassification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARCPress; 2008. pp 145-147.
33. Enver T. B-cell commitment: Pax-5 is the deciding factor. Curr Biol 1999;9:933-935.
34. Fuxa M, Busslinger M. Reporter gene insertions reveal a strictly Blymphoid-specific expression pattern of Pax-5 in support of its Bcell identity function. JImmunol 2007;178:3031-3037.
35. Schoumans J, Johansson B, Corcoran M, et al. Characterisation of dic(9;20)(p11-13;q11) in childhood B-cell precursor acute lymphoblastic leukemia by tiling resolution array-based comparative genomic hybridization reveals clustered breakpoints at 9p13.2 and 20q11.2. Br JHaematol 2006;135:492-499.
36. Usvasalo A, Savola S, Räty L, et al. CDKN2Adeletions in acute lymphoblastic leukemia of adolescents and young adults: an array CGHstudy. Leuk Res 2008;32:1228-1235.
37. Xu W, Lu X, Kim Y, et al. Deletion of 14q24.1 approximately q24.3 in a patient with acute lymphoblastic leukemia: a hidden chromosomal anomaly detected by array-based comparative genomic hybridization. Cancer Genet Cytogenet 2008;185:43-46.
38. Yip SF, Wan TS, Chan LC, et al. Trisomy 4 as sole karyotypic abnormality in acute lymphoblastic leukemia: different clinical features and treatment response between Band Tphenotypes? Cancer Genet Cytogenet 2006;164:94-95.
39. Mirebeau D, Acquaviva C, Suciu S, et al. The prognostic significance of CDKN2A, CDKN2Band MTAPinactivation in B-lineage acute lymphoblastic leukemia of childhood. Results of the EORTCstudies 58881 and 58951. Haematologica 2006;91:881-885.
40. Strefford JC, van Delft FW, Robinson HM, et al. Complex genomic alterations and gene expression in acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21. Proc Natl Acad Sci USA2006;103:8167-8172.
41. Schraders M, Van Reijmersdal SV, Kamping EJ, et al. Highresolution genomic profiling of pediatric lymphoblastic lymphomas reveals subtle differences with pediatric acute lymphoblastic leukemias in the B-lineage. Cancer Genet Cytogenet 2009;191:27-33.